Iros Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 8.67%
- Profit Growth 11.21%
- Ebitda 6.45%
- Net Worth 15.83%
- Total Assets 11.26%
About Iros Pharma
Iros Pharma Private Limited (IPPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 September 2019 (Five years and five months 1 days old ). Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Automotive Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Deepa Baddela, Reshma Adduri, and Somnath Adduri serve as directors at the Company.
Company Details
-
Location
Krishna, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24299AP2019PTC112905
-
Company No.
112905
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Sep 2019
-
Date of AGM
13 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Iros Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepa Baddela | Managing Director | 25-Jan-2023 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Reshma Adduri
|
Director | 16-Sep-2019 | Current |
|
Somnath Adduri
|
Director | 16-Sep-2019 | Current |
Financial Performance of Iros Pharma.
Iros Pharma Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 8.67% increase. The company also saw a substantial improvement in profitability, with a 11.21% increase in profit. The company's net worth Soared by an impressive increase of 15.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Iros Pharma?
In 2022, Iros Pharma had a promoter holding of 20.00% and a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Iros Pharma?
Unlock and access historical data on people associated with Iros Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Iros Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Iros Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.